
Treace Medical Concepts, Inc.
- Jurisdiction
United States - ISIN
US89455T1097 (TMCI )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. Read full profile
Stock price
Fundamentals
- Net revenue
€182.99M - Gross margin
80.1% - EBIT
-€41.00M - EBIT margin
-22.4% - Net income
-€42.10M - Net margin
-23.0%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
N/A | N/A |
Dividends
No dividend payouts
Earnings Calls
Latest earnings call: August 8, 2025
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Buy |